- Report
- January 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,191GBP
- Report
- July 2024
- 120 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- May 2025
- 114 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2689EUR$3,000USD£2,307GBP
- Report
- February 2024
- 118 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- April 2023
- 147 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- April 2024
- 114 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- April 2024
- 140 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- September 2024
- 331 Pages
Asia Pacific
From €3315EUR$3,699USD£2,844GBP
- Report
- August 2024
- 117 Pages
Africa, Middle East
From €3092EUR$3,450USD£2,653GBP
- Report
- August 2024
- 127 Pages
North America
From €3092EUR$3,450USD£2,653GBP
- Report
- January 2023
- 282 Pages
Global
From €3226EUR$3,600USD£2,768GBP
- Report
- November 2023
- 439 Pages
Global
From €3226EUR$3,600USD£2,768GBP
- Report
- October 2023
Global
From €3226EUR$3,600USD£2,768GBP
- Report
- July 2023
- 444 Pages
Global
From €3226EUR$3,600USD£2,768GBP
- Report
- March 2026
- 154 Pages
China
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2026
- 172 Pages
Germany
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2026
- 190 Pages
India
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2026
- 336 Pages
Canada
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2025
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more